Recombinant EGFR (Panitumumab Biosimilar) 抗体
Quick Overview for Recombinant EGFR (Panitumumab Biosimilar) 抗体 (ABIN7795086)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
-
-
Expression System
- Mammalian cells
-
原理
- Panitumumab Biosimilar, Endotoxin 0.05 EU/mg
-
产品特性
- Panitumumab, a fully anti-EGFR (epidermal growth factor receptor, EGF receptor, ErbB-1 and HER1 in humans) human monoclonal antibody, is used for the treatment of refractory EGFR-expressing metastatic colorectal cancer in patients with non-mutated (wild-type) KRAS".
-
纯化方法
- Protein A or G affinity column
-
纯度
- >95 % by reducing SDS-PAGE
-
内毒素水平
- Less than 0.5 EU/mg of protein as determined by LAL method
-
免疫原
- Human EGFR / ErbB-1 / HER1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- > 3 mg/mL
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- EGFR (Panitumumab Biosimilar)
-
别名
- Panitumumab Biosimilar
-
物质类
- Biosimilar
抗原
-